Biosino Bio-Technology & Science, Inc. Class H (8247) Price & Analysis

0 Followers

8247 Stock Chart & Stats

HK$0.85

HK$0.00(0.00%)

At close: Jan 08 4:00 PM EST

HK$0.85

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.73 - HK$7.00

Previous CloseN/A

Volume0.00

Average Volume (3M)28.60K

Market Cap

HK$457.27M

Enterprise ValueHK$451.97

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.34

Next Earnings

Mar 31, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding64,286,140

10 Day Avg. Volume29,400

30 Day Avg. Volume28,600

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

8247 FAQ

What was Biosino Bio-Technology & Science, Inc. Class H’s price range in the past 12 months?

Biosino Bio-Technology & Science, Inc. Class H lowest stock price was HK$0.73 and its highest was HK$7.00 in the past 12 months.

What is Biosino Bio-Technology & Science, Inc. Class H’s market cap?

Biosino Bio-Technology & Science, Inc. Class H’s market cap is HK$457.27M.

When is Biosino Bio-Technology & Science, Inc. Class H’s upcoming earnings report date?

Biosino Bio-Technology & Science, Inc. Class H’s upcoming earnings report date is Mar 31, 2027 which is in 184 days.

How were Biosino Bio-Technology & Science, Inc. Class H’s earnings last quarter?

Biosino Bio-Technology & Science, Inc. Class H released its earnings results on Mar 31, 2026. The company reported -HK$0.251 earnings per share for the quarter.

Is Biosino Bio-Technology & Science, Inc. Class H overvalued?

According to Wall Street analysts Biosino Bio-Technology & Science, Inc. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Biosino Bio-Technology & Science, Inc. Class H pay dividends?

Biosino Bio-Technology & Science, Inc. Class H does not currently pay dividends.

What is Biosino Bio-Technology & Science, Inc. Class H’s EPS estimate?

Biosino Bio-Technology & Science, Inc. Class H’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Biosino Bio-Technology & Science, Inc. Class H have?

Biosino Bio-Technology & Science, Inc. Class H has 64,286,140 shares outstanding.

What happened to Biosino Bio-Technology & Science, Inc. Class H’s price movement after its last earnings report?

Biosino Bio-Technology & Science, Inc. Class H reported an EPS of -HK$0.251 in its last earnings report. Following the earnings report the stock price went down -2.615%.

Which hedge fund is a major shareholder of Biosino Bio-Technology & Science, Inc. Class H?

Currently, no hedge funds are holding shares in HK:8247

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Biosino Bio-Technology & Science, Inc. Class H Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

-10.74%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Biosino Bio-Technology & Science, Inc. Class H

Biosino Bio-Technology & Science, Inc. engages in the manufacture, sale, and distribution of in-vitro diagnostic reagents and pharmaceutical products. It distributes a variety of mono and double diagnostic reagent products which are used by various medical institutions, independent laboratories, government public health testing centers, and individuals. The company was founded in 1988 and is headquartered in Beijing, China.